Neurovascular Solutions
Automated neurovascular emergency solution for stroke management
Software · On PremiseCompany source
Company profile
About Olea Medical
Olea Medical is a medical imaging software company that develops advanced post-processing solutions for radiology and clinical diagnostics. The company specializes in automated, AI-powered analysis tools that support healthcare professionals in emergency care, oncology, neurology, cardiology, and women's health. Their flagship Automation Platform V1.5 provides intelligent automated solutions for neurovascular emergencies, particularly stroke management, delivering real-time analysis and automated reporting to optimize patient flow and clinical decision-making. The platform supports both MRI and CT imaging modalities and integrates seamlessly with PACS systems and radiologist workflows. Olea Medical's solutions are designed to standardize imaging workflows, reduce radiologist workload, and improve diagnostic confidence through quantitative analysis and advanced visualization tools. The company's neuro-oncology solution offers comprehensive MRI analysis with over 100 supporting clinical publications, while their emergency imaging suite includes automated detection of intracranial hemorrhage, large vessel occlusion, and CT perfusion analysis. Olea Medical serves hospitals, imaging centers, and healthcare systems globally, with a focus on providing multi-vendor compatible solutions that integrate with neuronavigation systems and clinical workflows. The company maintains a strong commitment to clinical evidence and education through their Olea Medical Academy and extensive scientific publication database.
Company description Olea Medical official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Olea Medical?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Aortic dissection
- Brain tumors (gliomas, low-grade and high-grade)
- Chest pain
- Intracranial hemorrhage
- Large vessel occlusion
- Neurological diseases
- Pulmonary embolism
- Stroke (ischemic and hemorrhagic)
Who it serves
- Emergency departments
- Hospitals
- Imaging centers
- Neurosurgery departments
- Radiology departments
Deployment & integration
Cloud Saas · On Premise deployment with recorded integration context.
Recorded integration context: Email, Mobile devices, Multi-vendor CT systems, Multi-vendor MRI systems, Neuronavigation systems, PACS.
Geographic context
MarketsFrance · Global
Company sourceOfficial website
Company milestones
Platform expansion
Launch of Automation Platform V1.5 with enhanced speed, stability, and efficacy. Publication of reference book 'Spin To The Limit - MRI Principles and Physical Challenges' with 40+ international experts. Participation in JFR 2026 congress.
Partnerships
Recorded partners
- UC Irvine Center for AI in Diagnostic Medicine
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Cardiology Solutions
Complete post-processing solution for cardiac MRI
Software · On PremiseCompany source
APT CEST
Advanced MRI post-processing for functional characterization
Software · On PremiseCompany source
auto Chest Pain
AI-powered solution for chest pain emergency management
Software · On PremiseCompany source
Functional MRI
Functional characterization through advanced MRI
Software · On PremiseCompany source
Neurology - Neuro-oncology MRI Solution
Complete MRI solution for brain tumor analysis and treatment monitoring
Software · On PremiseCompany source
Oncology Imaging Solution
Complete solution for oncology imaging analysis
Software · On PremiseCompany source
Women's Health Imaging
Rationalizing and automating routine imaging for women's health
Software · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Diagnostic Accuracy of APTw and NOEw MRI Metrics for IDH Mutation and 1p/19q Codeletion Prediction in Gliomas.NMR in biomedicine · Sep 1, 2026
Radiation dose reduction in computed tomography perfusion of acute ischemic stroke patients using a denoising autoencoder.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · Jul 25, 2026
Linking human brain functional connectivity to underlying neurotransmission.bioRxiv : the preprint server for biology · May 5, 2026
Estimating blood oxygen saturation through susceptibility source separation: A new standpoint on quantitative BOLD models.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · Mar 1, 2026
Pharmacological MRI: Utility in Understanding Drug Mechanisms in Psychiatric Disorders.Journal of magnetic resonance imaging : JMRI · Feb 1, 2026
Quantitative neuroimaging meets normative modelling: the last mile for precision medicine applications.NeuroImage · Jan 1, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Neuro Insight V1.0K243681 · 510k · Jul 23, 2025
MR DWI/FLAIR Measurement V1.0K230552 · 510k · Apr 26, 2023
MR Diffusion Perfusion Mismatch V1.0K223502 · 510k · Jan 13, 2023
breastscape v1.0K211431 · 510k · Aug 2, 2021
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Hemorrhage detection accuracy
Exceeding 95% accuracy in multiple internal and external benchmarks
Vessel occlusion detection accuracy
Higher than 97% accuracy in clinical benchmarks
Workflow optimization
Real-time processing speeds up routine tasks and improves workflow in emergency departments
Patient triage
Automated priority-based case triage in real-time for emergency stroke cases
UC Irvine Center for AI in Diagnostic Medicine
Hemorrhage detection and vessel occlusion detection in stroke cases
95% accuracy in hemorrhage detection and 97% accuracy in vessel occlusion detection
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Dr Peter Chang
Co-Director, Center for AI in Diagnostic Medicine, Assistant Professor-in-Residence Radiological Sciences
06 · Company updates
Updates from Olea Medical
Recent articles published on Olea Medical's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.